Published April 28, 2026 | Version v1
Preprint Open

Compound Ciwujia for Depression-Related Cardiac Risk

Authors/Creators

  • 1. MedicOath

Description

ClinicalTrials.gov shows NCT07085143 testing Compound Ciwujia Granules for depression (Phase 4). Traditional Chinese Medicine compound containing Acanthopanax senticosus. Depression strongly correlates with cardiovascular disease risk. FAERS data shows antidepressants like PAXIL (508 reports) and ZOLOFT (278 reports) associated with heart disease, suggesting cardiac effects of mood disorders.

Notes

IPFS: QmNSVcL6y4sxVVe1kYMNqevb7VCZVudrHPPZ65NAMjMh7i. TX: 0xad7e41635935d1bb96ee40f580f53c8022acc0c0096ecef06ccb68c413357116. CC0.

Files

hypothesis.json

Files (323 Bytes)

Name Size Download all
md5:62236faa4bc1ce36d689ec0395cd0b08
323 Bytes Preview Download